Answers are grounded in this paper and cite their sources.
Many biomarkers have been evaluated for use in sepsis. Most of the biomarkers had been tested clinically, primarily as prognostic markers in sepsis; relatively few have been used for diagnosis. None has sufficient specificity or sensitivity to be routinely employed in clinical practice. PCT and CRP have been most widely used, but even these have limited ability to distinguish sepsis from other inflammatory conditions or to predict outcome.
No takes yet. Share an insight, caveat, or question.
Pierrakos et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: